Analyst ratings and price targets can significantly influence a stock's price. In this case, Barclays, a reputable financial institution, has maintained an Overweight rating on Boston Scientific and raised its price target. This suggests that they believe the stock is undervalued and has potential for growth, which could lead to increased investor interest and a rise in the stock's price.